000 | 01432 a2200421 4500 | ||
---|---|---|---|
005 | 20250513155107.0 | ||
264 | 0 | _c19990107 | |
008 | 199901s 0 0 eng d | ||
022 | _a0014-4800 | ||
024 | 7 |
_a10.1006/exmp.1998.2231 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYuan, Q X | |
245 | 0 | 0 |
_aMechanisms of mallory body formation induced by okadaic acid in drug-primed mice. _h[electronic resource] |
260 |
_bExperimental and molecular pathology _cOct 1998 |
||
300 |
_a87-103 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aDicarbethoxydihydrocollidine |
650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 |
_aInclusion Bodies _xmetabolism |
650 | 0 | 4 |
_aKeratins _xmetabolism |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C3H |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aOkadaic Acid _xpharmacology |
650 | 0 | 4 |
_aPhosphothreonine _xmetabolism |
700 | 1 | _aNagao, Y | |
700 | 1 | _aGaal, K | |
700 | 1 | _aHu, B | |
700 | 1 | _aFrench, S W | |
773 | 0 |
_tExperimental and molecular pathology _gvol. 65 _gno. 2 _gp. 87-103 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/exmp.1998.2231 _zAvailable from publisher's website |
999 |
_c9792282 _d9792282 |